Some research suggests that microtubule-associated protein tau (MAPT) or shortly Tau mutations, which are known to cause a specific FTD phenotype called FTD-Tau, may be responsible for part of the clinical profile of some ALS cases as well [14,15]. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.